Growth Hormone Secretagogues Guide: Best GHS Peptides Ranked (2026)

What Are Growth Hormone Secretagogues (GHS)?

Growth hormone secretagogues are a class of research compounds that stimulate the pituitary gland to release growth hormone (GH) either by mimicking ghrelin, stimulating GHRH receptors, or both simultaneously. Unlike exogenous HGH, which floods the system with a static dose of growth hormone, secretagogues work with the body's own pulsatile release mechanisms — making them a subject of significant interest in aging, metabolism, and recovery research.

In research settings, GHS compounds are used to model the effects of amplified GH pulses on lean body composition, sleep architecture, cellular repair, IGF-1 axis activity, and metabolic function. There are two main mechanistic categories:

• GHRH Analogues: Peptides that bind to GHRH receptors and amplify natural GH pulses. Examples: CJC-1295, Sermorelin, Tesamorelin.
• Ghrelin Mimetics (GHRPs): Compounds that activate the GHS-R1a receptor to stimulate GH release. Examples: Ipamorelin, GHRP-2, GHRP-6, MK-677.

Because they preserve the body's natural feedback loop, most secretagogues do not suppress endogenous GH production the way exogenous HGH does — a key distinction in research design.

Growth Hormone Secretagogues Compared: At a Glance

The table below summarises the most commonly researched GHS compounds across key variables relevant to preclinical and research-context decision-making.

Top Growth Hormone Secretagogues: Ranked and Reviewed

🥇 1. Ipamorelin + CJC-1295 — Best Combination for Research

Ipamorelin is widely regarded as the cleanest GHRP in the research space. Its selectivity for GH release without meaningfully elevating cortisol, prolactin, or ACTH makes it a preferred choice for researchers who want an isolated look at GH pulse dynamics without confounding hormonal variables.

When combined with CJC-1295 (a GHRH analogue), the two compounds work synergistically — CJC-1295 raises the ceiling for GH secretion while Ipamorelin triggers clean, amplified pulses. This combination has been used extensively in research models examining lean tissue support, recovery, and sleep-phase GH secretion.

• Pros: Highly selective, minimal hormonal side effects, strong synergy, well-characterised in literature
• Cons: Requires subcutaneous injection, peptide stability requires cold chain storage
• Typical research dosing: 100–300 mcg Ipamorelin + 100–300 mcg CJC-1295 (without DAC), administered 2–3x daily in preclinical studies
• Who should prioritise this: Researchers modelling clean GH elevation without cortisol confounds

🥈 2. MK-677 (Ibutamoren) — Best Oral Option

MK-677 is a non-peptide ghrelin mimetic that is orally bioavailable — a significant practical advantage over injection-based peptides. It produces sustained elevation of GH and IGF-1 over a 24-hour window, making it uniquely suited for research designs that require consistent GH axis activation rather than pulsatile spikes.

Published research has examined MK-677 in the context of GH deficiency models, sleep quality, nitrogen retention, and bone density. Its long half-life simplifies research protocols considerably.

• Pros: Oral route, long half-life, strong IGF-1 elevation, extensive published research base
• Cons: Can increase appetite significantly, mild water retention observed in some studies, not pulsatile
• Typical research dosing: 10–25 mg oral daily in human-equivalent models
• Who should prioritise this: Researchers wanting oral administration, sustained GH/IGF-1 models, or studies requiring once-daily dosing convenience

🥉 3. Sermorelin — Best for Physiologic GH Modelling

Sermorelin is a truncated analogue of endogenous GHRH (the first 29 amino acids) and is one of the oldest GHS compounds in research. Because it closely mimics natural GHRH, it produces highly physiologic GH pulses and is subject to normal pituitary feedback — meaning GH release self-regulates, preventing supraphysiologic overshoot.

This makes Sermorelin particularly valuable in age-related GH decline research and models where mimicking natural hormone rhythms is the priority rather than maximising GH output.

• Pros: Highly physiologic, self-regulating, long safety record in literature, preserves natural feedback
• Cons: Weaker GH pulse than synthetic GHRPs, very short half-life (requires precise timing)
• Typical research dosing: 200–500 mcg SubQ, typically pre-sleep in research models
• Who should prioritise this: Researchers focused on somatopause models or age-related GH research

4. GHRP-2 — Strongest Raw GH Release

GHRP-2 produces among the highest GH pulses of any research secretagogue, making it useful when maximum GH stimulation is the experimental objective. However, it also significantly elevates cortisol and prolactin — which can confound research results and limits its utility in studies where clean GH effects are the target.

• Pros: Maximum GH output, well-documented dose-response curve
• Cons: Significant cortisol and prolactin elevation, less selective than Ipamorelin
• Who should prioritise this: Researchers specifically studying maximum GH secretion capacity

5. Tesamorelin — Best for Visceral Fat Research

Tesamorelin is a stabilised GHRH analogue with an established clinical research record, particularly around HIV-associated lipodystrophy and visceral adiposity models. Its targeted activity on the GHRH receptor with low cortisol impact makes it a precise tool for metabolic GH research.

• Pros: FDA-approved in clinical context (Egrifta), strong visceral fat research support, clean hormonal profile
• Cons: Expensive relative to other GHS, short half-life, less commonly stocked by research vendors
• Who should prioritise this: Metabolic researchers focused on adipose tissue and lipid modelling

Which Growth Hormone Secretagogue Is Right for Your Research?

Can Growth Hormone Secretagogues Be Combined?

Yes — and in research settings, the most common and well-validated approach is combining a GHRH analogue with a GHRP. This dual-pathway stimulation produces significantly greater GH output than either compound alone, because:

• GHRH analogues (CJC-1295, Sermorelin) increase the amount of GH available in pituitary somatotrophs
• GHRPs (Ipamorelin, GHRP-2) trigger the actual release pulse
• Together, they act on two separate receptors, creating a synergistic amplification effect

The Ipamorelin + CJC-1295 (no DAC) combination is the most studied dual-GHS stack and represents the benchmark for clean GH research protocols. MK-677 is sometimes used alone due to its oral convenience and 24-hour action, though some researchers add a short-acting GHRP on top for enhanced pulsatility data.

Researchers should note that combining multiple GHS compounds increases the complexity of data interpretation — controlling for compound interactions requires careful study design.

Where to Buy Growth Hormone Secretagogues for Research

When sourcing GHS peptides for research purposes, vendor quality directly impacts result validity. A compound with 90% purity introduces a 10% unknown variable into every data point. Key criteria to apply when evaluating vendors:

• Third-party HPLC/MS testing: Independent lab verification of purity, not just in-house claims
• Certificate of Analysis (COA) availability: Should be downloadable per batch, not a generic document
• US-based manufacturing or cold-chain compliance: Critical for peptide integrity during shipping
• Research-only positioning: Legitimate vendors sell for research purposes only and do not make clinical claims
• >98% purity standard: The minimum acceptable threshold for research-grade peptides

Ascension Peptides is a frequently cited option among researchers for meeting these criteria across their GHS peptide range, including Ipamorelin, CJC-1295, Sermorelin, and MK-677.

Frequently Asked Questions: Growth Hormone Secretagogues